Qista and French Red Cross Deploy Mosquito Protection for Vulnerable Youth Amidst Chikungunya Concerns
A collaborative effort between Qista and the French Red Cross is bolstering preventative measures against chikungunya in Saint-Gilles, Reunion, with a particular focus on protecting at-risk children. The initiative comes as health officials continue to monitor active transmission of the virus, despite a declared end to the epidemic phase.
As part of a broader commitment to public health, Qista, a company headquartered in Senas, France, donated two Qista ONE terminals to the Maison d’Enfants à Caractère Social (MECS) Les Filaos, a French Red Cross facility providing care for 24 minors under child protection services. This donation aims to strengthen preventative efforts in a region where chikungunya transmission remains a concern.
The 2025 chikungunya epidemic on Reunion Island resulted in 43 fatalities, underscoring the severity of the threat. In response, Qista, working alongside BHL Prophylaxie, is providing crucial protection against mosquito-borne illnesses to a vulnerable population.
Public Health Situation in Reunion
According to the latest data released by Public Health France on November 7, 2025, chikungunya has caused 43 deaths and 54,552 confirmed cases of infection on Reunion Island this year. While the regional health authority (ARS) downgraded the alert level to 2 of the ORSEC system for combating arboviruses on June 27, 2025 – signifying a shift from epidemic to moderate viral circulation – vigilance remains paramount.
Currently, only one confirmed case of contamination was reported in week 43. However, authorities emphasize that the virus continues to circulate, and residents are urged to maintain preventative measures to eradicate the disease. Protecting oneself from mosquito bites, even while sick, is crucial to prevent further spread.
Deployment and Ongoing Support
The Qista ONE terminals were installed on May 28, 2025, with operational support from local partner BHL Prophylaxie. To maximize effectiveness during the peak epidemic period, six months of operation were initially provided. BHL Prophylaxie is responsible for ongoing maintenance and the supply of consumables through the end of the year, ensuring the continued functionality of the protective devices.
This collaborative effort highlights the importance of public-private partnerships in addressing public health challenges and safeguarding vulnerable communities against the ongoing threat of chikungunya and other mosquito-borne diseases.
